| Old Articles: <Older 27231-27240 Newer> |
|---|
 |
The Motley Fool
November 13, 2007
Sham Gad |
The Art of Selling High You can buy low, but if you don't know the fair value of a company, and when to sell, your success will hinge on luck.   |
The Motley Fool
November 13, 2007
Rick Aristotle Munarriz |
Have Website, Will Travel It's been a busy week for online-travel site investors, with several of the main players reporting earnings. Let's compare the three stateside leaders: Orbitz... Priceline.com...Expedia... |
The Motley Fool
November 13, 2007
Rich Smith |
Numbers Up, Stock Down at NVIDIA Third-quarter results were superb, but a downturn in the semiconductor industry drags NVIDIA down with most of the sector. |
The Motley Fool
November 13, 2007
Brian Orelli |
Merck: Case Closed? Now that Merck has settled its lawsuit, it can get back to business, focusing on continued growth from its cholesterol drugs, new diabetic medication, and cervical cancer vaccine. Investors, take note. |
The Motley Fool
November 13, 2007
Matt Koppenheffer |
Blackstone's Foggy Future Private equity firm Blackstone reported a third-quarter loss against solid revenue growth -- and a murky future looking forward. |
The Motley Fool
November 13, 2007
Rich Smith |
Foolish Forecast: Applied Materials Not So Shiny In advance of earnings, analysts wonder if the semiconductor equipment maker will beat their earnings estimates yet again. |
The Motley Fool
November 13, 2007
Anders Bylund |
AccessIT: The Next Invisible Media Giant AccessIT provides systems and software for every step in the digital distribution and projection at movie theaters, and is the leader in this emerging field. Investors, take note. |
The Motley Fool
November 12, 2007
Mac Greer |
Fool Video: Great Stocks for Bad Markets, Disney's Next Act, and Akamai's Bright Future What are the best stocks to own in a volatile market? What will Disney do next? Will Akamai continue to deliver in the wake of Limelight's deal with Microsoft? These questions and others are answered in this video. |
The Motley Fool
November 12, 2007
Brian Orelli |
Valuing a Breakup Abraxis makes its final earnings report before it becomes two companies. Its hospital-based products division will hereafter be known as APP Pharmaceuticals. |
The Motley Fool
November 12, 2007
Jack Uldrich |
Foolish Book Review: "Microtrends" Microtrends: The Small Forces Behind Tomorrow's Big Changes, the new book by Mark Penn and E. Kinney Zalesne, explains how understanding small trends today could lead investors to tomorrow's potentially profitable opportunities. |
| <Older 27231-27240 Newer> Return to current articles. |
